tiprankstipranks
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
US Market

Lyell Immunopharma (LYEL) Cash flow

Compare
108 Followers

Lyell Immunopharma Cash Flow

LYEL's free cash flow for Q4 2024 was $-47.29M. For the 2024 fiscal year, LYEL's free cash flow was decreased by $3.52M and operating cash flow was $-47.24M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -162.39M$ -163.69M$ -169.56M$ -126.25M$ -160.87M
Investing Cash Flow
$ 122.42M$ 184.05M$ -11.54M$ -121.57M$ -273.52M
Financing Cash Flow
$ 1.33M$ 1.74M$ 10.63M$ 401.24M$ 476.79M
End Cash Position
$ 107.29M$ 145.93M$ 123.83M$ 294.29M$ 140.87M
Free Cash Flow
$ -162.86M$ -166.38M$ -193.83M$ -191.75M$ -212.35M
Currency in USD

Lyell Immunopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis